HTL

Hyaluronic acid, also known as Hyaluronan, is a biopolymer that is naturally present in the human body. It has been used for many years as a raw material or ingredient for medical products in various fields including ophthalmology, rheumatology medical aesthetics and dermatology.
HTL Biotechnolog...

Building on the success of hyaluronic acid, HTL now wants to bring heparosan to market. Heparosan is a promising new biopolymer for the design of innovative medical and pharmaceutical devicesHeparosan is a glycosaminoglycan, a natural biopolymer, produced by HTL Biotechnology from substances of non-animal ...

HTL Biotechnology offers expert guidance and support to companies venturing into the industrial production of a modified Hyaluronic Acid compound, ensuring transparent and efficient processes.

New functionalities thanks to chemical modification: 
Optimizing ...

PDRN is a fast-growing biopolymer with unique advantages. Our company has 45 years' experience in DNA production. We are recognized for being able to supply DNA for topical and injectable applications, with a very low level of impurities. 
Key role at molecular level : 
- Key role in cell...

Sodium DNA is a raw material for cosmetics with unique properties. Our company has 45 years' experience in DNA production. We are recognized for our ability to supply DNA for topical and injectable applications, with very low levels of impurities. Sodium DNA, is DNA that has been extracted and purified to ...

IMCAS, the world’s leading congress dedicated to dermatology, plastic surgery, and aesthetics.

Feel the difference with HTL inside !
HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.

Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.

At HTL Biotechnology, our mission is to unleash the potential of Hyaluronic Acid and biopolymers.

For over 30 years, our teams have been developing and perfecting a pharmaceutical-grade biopolymer platform that provides customized solutions to pharmaceutical laboratories and medical device manufacturers worldwide in therapeutic areas such as Ophthalmology, Rheumatology, Dermatology and Medical Aesthetics.

The biggest international pharma industry event is back in Barcelona.The HTL team was present to welcome people and discuss our products and values, also our latest advancements with biopolymers for medical applications.

Feel the difference with HTL inside !
HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.

Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 400 million syringes of hyaluronic acid have been safely used since 2006.

At HTL Biotechnology, our mission is to unleash the potential of Hyaluronic Acid and biopolymers.

For over 30 years, our teams have been developing and perfecting a pharmaceutical-grade biopolymer platform that provides customized solutions to pharmaceutical laboratories and medical device manufacturers worldwide in therapeutic areas such as Ophthalmology, Rheumatology, Dermatology and Medical Aesthetics.

HTL Biotechnology's new corporate social responsibility strategy will focus on accelerating the company’s commitment to its environment, local ecosystem and employees. 

HTL Biotechnology's engagements have been awarded an Ecovadis gold medal in 2023 and are certified by ISO 14001:2015.